Study identification

EU PAS number

EUPAS1000000378

Study ID

1000000378

Official title and acronym

Initiation of Sodium-Glucose Cotransporter 2 inhibitors after first hospitalization for heart failure: a population-based cohort study

DARWIN EU® study

No

Study countries

France

Study description

This study aims to describe SGLT-2i initiation after discharge from first heart failure hospitalization in France between 2021 and 2023.

Study status

Finalised
Research institutions and networks

Institutions

Contact details

Paul Gautier 0009-0008-9934-8432

Primary lead investigator
ORCID number:
0009-0008-9934-8432

Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:

Data analysis start date

Planned:

Date of final study report

Planned:
Actual:
Sources of funding
No external funding
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable